1. Togami S, Kawamura T, Fukuda M, Yanazume S, Kamio M, Kobayashi H. Clinical management of uterine cervical mullerian adenosarcoma: a clinicopathological study of six cases and review of the literature. Taiwan J Obstet Gynecol 2018; 57: 479-482.
2.
Chin PS, Chia YN, Lim YK, Yam KL. Diagnosis and management of Müllerian adenosarcoma of the uterine cervix. Int J Gynaecol Obstet 2013; 121: 229-232.
3.
Rana IA, Hassan U, Bashir S, Hussain M, Shakeel M, Mushtaq S. Müllerian adenosarcoma: a single-centre experience of 59 cases of this rare entity. Cureus 2021; 13: e13360.
4.
Limaiem F, Ben Aissia N. Unveiling the intriguing grape-like mass: uterine cervical adenosarcoma. Clin Case Rep 2024; 12: e8683.
5.
Bruguier H, Maalouf N, Smyth SL, Damato S, Reddy P, Soleymani Majd H. Rare Mullerian adenosarcoma of the uterine cervix arising on a background of endometriosis: a diagnostic challenge with risk of malignant transformation – a case report and review of the current literature. Clin Case Rep 2024; 12: e9075.
6.
Zhu X, Peng C, Huang Y, Zhou Y. Uterine cervical Müllerian adenosarcoma possibly arising from ovarian cystadenofibroma: a case report and review of the literature. Front Oncol 2023; 12: 1064851.
7.
Lin-Satoi E, Kaneshiro T, Kanda R, Matsuda M, Sasajima Y, Ikeda SI. Uterine cervical adenosarcoma showing an endophytic growth pattern. J Med Cases 2022; 13: 402-407.
8.
Wang Q, Sun S, Cai J, Yang L, Lv G, Yang Q. Uterine adenosarcoma: a case report and review of the literature. Am J Nucl Med Mol Imaging 2023; 13: 70-76.
9.
Qing X, Xie M, Guo H, Zhang L Ye J, Zhang Y, et al. Mullerian adenosarcoma accidentally detected and coexisting with cervical carcinoma in situ: a rare case report. Front Oncol 2024; 14: 1482768.
10.
Pinto A, Howitt B. Uterine adenosarcoma. Arch Pathol Lab Med 2016; 140: 286-290.
11.
Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, et al. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecol Oncol Rep 2021; 39: 100913.
12.
Morales F DA, Medina R ML, Trujillo LM, Beltrán MI, Dulcey IC. Müllerian adenosarcoma of the uterine cervix with sarcomatous overgrowth: a case report of aggressive disease in a young patient. Int J Surg Case Rep 2016; 27: 155-161.
13.
Hodgson A, Amemiya Y, Seth A, Djordjevic B, Parra-Herran C. High-grade Müllerian adenosarcoma: genomic and clinicopathologic characterization of a distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior. Am J Surg Pathol 2017; 41: 1513-1522.
14.
Ban Y, Fischer JV, Maniar KP, Haiyang Guo, Chang Zeng, Li Y, et al. Whole-genome sequencing and target validation analysis of Müllerian adenosarcoma: a tumor with complex but specific genetic alterations. Front Oncol 2020; 10: 538.
15.
Yao R, Wu P, Sung CJ, Lamson JA, Zhang C. Malignant mixed Mullerian tumor arising from endometriosis in the groin: a case report and literature review. Int J Surg Pathol 2023; 31: 338-342.
16.
Palicelli A, Torricelli F, Tonni G, Bisagni A, Zanetti E, Zanelli M, et al. Primary carcinomas of the episiotomy scar site: a systematic literature review. Curr Oncol (Toronto, Ont.) 2025; 32: 65.
17.
Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 2001; 20: 133-139.
18.
Yantiss RK, Clement PB, Young RH. Neoplastic and preneoplastic changes in gastrointestinal endometriosis: a study of 17 cases. Am J Surg Pathol 2000; 24: 513-524.
19.
Salvin RE, Krum R, Van Dinh T. Endometriosis-associated intestinal tumors: a clinical and pathological study of 6 cases with a review of the literature. Hum Pathol 2000; 31: 456-463.
20.
Bassiouny D, El-Baz MA, Gamil TM, Shams N, Ismiil N, Dubé V, et al. Endometriosis associated ovarian cancer is a subset with a more favorable outcome and distinct clinical-pathologic characteristics. Int J Gynecol Pathol 2019; 38: 435-442.
21.
Mandato VD, Torricelli F, Mastrofilippo V, Valli R, Aguzzoli L, La Sala GB. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review. BMC Cancer 2018; 18:134.
22.
Chang HY, Changchien CC, Chen HH, Lin H, Huang CC. Extrauterine müllerian adenosarcoma associated with endometriosis and rectal villotubular adenoma: report of a case and review of the literature. Int J Gynecol Cancer 2005; 15: 361-365.
23.
Tenjimbayashi Y, Kobayashi Y, Suzuki Y, Satoh T, Horie K. Primary low-grade endometrial stromal sarcoma of the ovary arising from endometriosis: a case report. Cureus 2025; 17: e79530.
24.
Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol 2009; 10: 1188-1198.
25.
Nakai G, Matsutani H, Yamada T, Ohmichi M, Yamamoto K, Osuga K. Imaging findings of uterine adenosarcoma with sarcomatous overgrowth: two case reports, emphasizing restricted diffusion on diffusion weighted imaging. BMC Women’s Health 2021; 21: 416.
26.
Ray-Coquard I, Casali PG, Croce S, van HoudtW, Planchamp F, Friedlan- der M, et al. ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas. Int J Gynecol Cancer 2024; 34: 1499-1521.
27.
Nathenson MJ, Conley AP, Lin H, Fleming N, Lazar A, Wang WL, et al. The importance of lymphovascular invasion in uterine adenosarcomas: analysis of clinical, prognostic, and treatment outcomes. Int J Gynecol Cancer 2018; 28: 1297-1310.
28.
Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine adenosarcoma: a review. Curr Oncol Rep 2016; 18: 68.
29.
Bernard B, Clarke BA, Malowany JI, McAlpine J, Lee CH, Atenafu EG, et al. Uterine adenosarcomas: a dual-institution update on staging, prognosis and survival. Gynecol Oncol 2013; 131: 634-639.
30.
Yuan Z, Cao D, Yu M, Shen K, He Y. Uterine and cervical adenosarcoma: a retrospective study of overall oncologic outcomes and fertility preservation in early-stage disease. Oncologist 2019; 24: e870-e879.
